Immune checkpoint and angiogenic inhibitors for the treatment of hepatocellular carcinoma: It takes two to tangle Caecilia Sukowati; Loraine Kay D. Cabral; Claudio Tiribelli;

Camrelizumab combined with transcatheter arterial chemoembolization and sorafenib or lenvatinib for unresectable hepatocellular carcinoma: A multicenter, retrospective study Xiumei Jiang; Pan Wang; Ke Su; Han Li; Hao Chi; Fei Wang; Yu Liu; Ke Xu;

Treatment for hepatocellular carcinoma after immunotherapy Landon L. Chan; Tsz Tung Kwong; Johnny C.W. Yau; Stephen L. Chan;